A new high-potency glycine precipitated antihemophilic factor (AHF) concentrate. Treatment of classical hemophilia and hemophilia with inhibitors - Brinkhous, K. M; Shanbrom, E; Roberts, H. R; Webster, W. P; Fekete, L; Wagner, R. H (Journal of the American Medical Association, 1968)